Feedback EASD 2018

Conference Summaries

Clinical Trial

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (HARMONY Outcomes): a double-blind, randomised placebo-controlled trial

Symposium

Glycaemic variability and diabetic complications

Exercise & Diabetes

Exercise therapy for type 2 diabetes: a responder/non-responder issue?

Clinical Trial

Update and new findings from the Restoring Insulin SEcretin (RISE) study

Symposium

PCDE Symposium: management of type 2 diabetes in the young and elderly

Clinical Trial

Lesser eGFR decline with dulaglutide regardless of weight changes in people with type 2 diabetes and moderate to severe chronic kidney disease (AWARD-7)

Clinical Trial

UK Prospective Diabetes Study (UKPDS)

SGLT2, DPP4 & Kidney

SGLT2 and DPP-4 inhibitors: new avenues to protect the kidney

Clinical Trial

Efficacy and safety of LY3298176, a novel dual GIP/GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

Clinical Trial

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Clinical Trial

Cardiovascular and Renal Microvascular Outcome Study with Linagliptin in Patients with Type 2 Diabetes Mellitus (CARMELINA)

Prevention

PREVIEW: PREVention of diabetes through lifestyle Intervention and population studies in Europe and around the World

Download the EASD 2018 Slide Kit